SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: ghettogoulash7/18/2025 8:45:08 PM
1 Recommendation

Recommended By
bodish

  Read Replies (2) of 63281
 
FDA was already aware of the patient death in the Phase 1 trial of SRP-9004. Sarepta has chosen to disregard the "informal request" from someone at the agency to halt shipment of Elevidys. Maybe it was "this dude":

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext